Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

After baby's death, Kentucky parents sue infant formula maker at center of 2022 crisis

The parents of Kentucky baby who died last fall after drinking bacteria-tainted infant formula are the latest to sue manufacturer Abbott Nutrition

The Independent UK

Kamala Harris Is Running on 'Freedom.' Does She Mean More Than Just Abortion?

Gov. Tim Walz, the vice presidential candidate, told Republicans to "mind your own damn business" about abortion policy. Perhaps they should apply that concept further.

Reason

This anti-ageing supplement is going viral among Hollywood's elite; is it safe for your health?

Anti-ageing biohacking is the latest health trend that's fast gaining popularity among America's wellness fraternity. The promise to reverse age and defy related conditions indeed looks magical and pathbreaking. Nicotinamide adenine dinucleotide (NAD) supplements, a coenzyme form of niacin (Vitamin B3) have shown promise with its wonderful properties in DNA…

The Times of India

From analysis to the latest developments in health,
read the most diverse news in one place.

Diet Mountain Dew for the win? Why the favorite soda of both JD Vance and Tim Walz may not be a health drink.

The chartreuse soda contains three artificial sweeteners and various additives. How safe are they?

Fortune

Denmark gets Novo Nordisk to lower Ozempic prices

As Congress pushes for Medicare to cover anti-obesity drugs, puzzlement remains about who should get them, for how long, and at what price.

Fortune

Nara Smith TikTok DIY sunscreen causes more harm than good

As homemade sunscreen formulations are trending across social media, experts warn they are doing more harm than good.

Fortune

The FDA and psychedelic research

To move the drugs forward, manufacturers may need to follow the agency’s advice for elevating evidence quality

Salon

Read news from The Economist, FT, and more,
with one subscription

The Dangerous Side Of Healthcare: Selling Unregulated Devices And Increasing Patient Risk

According to the FDA's guidance document on when to submit a 510(k) for changes to an existing device, manufacturers must submit a new 510(k) if there are significant changes to the device's design, materials, or intended use.

International Business Times

3 Biotech Stocks With Anticipated Strong Earnings Reports

With highly effective drugs and treatment options, chronic disease prevalence, and adoption of technology, the biotech market is thriving. Hence, fundamentally solid biotech stocks Illumina (ILMN), Amgen (AMGN), and Entrada Therapeutics (TRDA) could be ideal with anticipated strong earnings reports. Read more.

StockNews.com

Project 2025: what does the rightwing blueprint say about abortion?

Policy playbook developed for potential Trump 2.0 term aims to ban abortion pills, increase surveillance and champion fetal personhood

The Guardian - US

Teens are getting colorectal cancer at unprecedented rates—but a little-known IRA provision is blocking new lifesaving treatments

Colorectal cancer rates in children soared 500% in the past two decades. A simple fix by Congress would put cancer research back in the fast lane.

Fortune

Flu vaccine will curb bird flu risk for US farm workers, CDC deputy director says

US launches major vaccination campaign in a bid to prevent healthcare strain and potential mutations of H5N1 virus

The Guardian - US

Psilocybin legislation is helping psychedelic drugs make a comeback – a drug researcher explains the challenges they face

An operations manager finds relief from her depression with the help of psilocybin, the primary psychoactive component of “magic mushrooms.” A veteran conquers his post-traumatic stress disorder through therapy using MDMA, a synthetic compound known on the street as “ecstasy” or “molly.” A stay-at-home mom tries LSD, otherwise known as…

The Conversation

FDA Approves New Blood Test For Colorectal Cancer Screening

FDA-approved Shield blood test offers a convenient and effective screening option for colorectal cancer, improving early detection rates.

Top News

FDA Approves First Blood Test For Colon Cancer Screening

FDA approves Guardant's Shield test for colon cancer screening in adults aged 45 and above, providing a convenient and accessible method for early detection.

International Business Times

New Generic Diabetes Drug Shows How Medical Innovation Works

The drugmaker Teva Pharmaceuticals made history in June by launching the first-ever generic version of a GLP-1 diabetes drug.

StockNews.com

3 Biotech Stocks With Revolutionary Pipelines to Buy Today

The biotech industry is experiencing rapid growth owing to new drug innovations and advancements in healthcare. To capitalize on the industry's expansion, it could be wise to invest in solid biotech stocks, Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), and Gilead Sciences (GILD), which have revolutionary pipelines. Read on….

1 … 91 92 93 94

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.